Detalhe da pesquisa
1.
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Blood
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728430
2.
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Blood
; 141(14): 1685-1690, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608320
3.
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
Blood
; 142(19): 1633-1646, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390336
4.
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
N Engl J Med
; 384(8): 705-716, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626253
5.
Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356448
6.
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma.
Eur J Nucl Med Mol Imaging
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456971
7.
Reproducible Radiomics Features from Multi-MRI-Scanner Test-Retest-Study: Influence on Performance and Generalizability of Models.
J Magn Reson Imaging
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733369
8.
Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients.
Haematologica
; 108(12): 3308-3320, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381752
9.
Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma.
Eur J Nucl Med Mol Imaging
; 50(12): 3697-3708, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493665
10.
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.
BMC Cancer
; 23(1): 1132, 2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990162
11.
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma.
Hematol Oncol
; 41(3): 453-462, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680428
12.
Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis.
Ann Hematol
; 102(11): 3091-3102, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355476
13.
A precision-based exercise program for patients with multiple myeloma.
Eur J Haematol
; 111(6): 930-937, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37727991
14.
Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma.
Future Oncol
; 19(13): 887-895, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212642
15.
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage.
Br J Haematol
; 199(1): 65-75, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608264
16.
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.
N Engl J Med
; 380(22): 2104-2115, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31141632
17.
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria.
Blood
; 135(18): 1517-1530, 2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107537
18.
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities.
Haematologica
; 107(8): 1891-1901, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045690
19.
[Clinical update-multiple myeloma]. / Klinisches Update Multiples Myelom.
Radiologe
; 62(1): 3-11, 2022 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-34967910
20.
[Positron emission tomography/computed tomography (PET/CT) in multiple myeloma]. / Positronen-Emissions-Tomographie/Computertomographie (PET/CT) beim multiplen Myelom.
Radiologe
; 62(1): 20-29, 2022 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-34921323